Archive for June, 2009
First vaccine against H1N1 virus from CSL to be available in 2 months
Australia’s CSL has already bagged orders worth $180 million from US govt.
Jubilant Biosys in pact with Endo Pharma on cancer drug discovery
Jubilant has signed similar drug discovery services deals with AstraZeneca, Eli Lilly, Amgen, Orion and Bio Leap over the last 18 months.
GSK in generic drugs pact with Dr Reddy’s
Toeing the Pfizer line, the GSK will supply over 100 branded generics from Dr Reddy’s to emerging markets.
Dr Reddy’s to hire 1,300 people braving recession; to recruit more women staff
India’s leading generic drug maker Dr Reddy’s Laboratories Ltd has announced its plans to hire 1,300 employees in various positions this year, despite recessionary trends that threatens to impact across the industries including pharma.
Clinical trial registration made compulsory in India from 15th June
Trial registration is now mandatory before the enrollment of the first patient
UK firms set sight on Indian clinical research sector
India is, currently, the second largest foreign direct investor in UK.
Pfizer bolsters lawsuit against Sun to block generic Lyrica (pregabalin)
Pfizer adds violation of a second patent on Lyrica in its case against Sun
Premature ejaculation pill Priligy (dapoxetine) to seek US FDA approval soon
Priligy (dapoxetine) is the first-ever oral pill approved to treat premature ejaculation
Kemwell sets up biopharmaceuticals facility on Boehringer Ingelheim’s Bi Hex platform technology
Indian contract manufacturing services provider Kemwell is building a new biopharmaceutical manufacturing plant in Bangalore, with technical assistance from the Germany-based Boehringer Ingelheim.
Bharat Biotech and Shantha Bio stand to gain as WHO includes global use of rotavirus vaccine
Indian vaccine makers including Bharat Biotech and Shantha Biotechnics see a bigger opportunity as the World Health Organisation (WHO) recommended that oral rotavirus vaccines be included in all national immunisation programmes.
